World Personalized Medicine Tests for Cancer

Published: January 31, 2017 - 29 Pages

Table of Contents

  • HIGHLIGHTS
  • WORLD OVERVIEW & FORECASTS
    • Introduction
      • Cancer Treatments
      • Cancer Risk Assessment
      • Cancer Screening
      • Cancer Monitoring
    • Technologies Used
      • Immunoassays
      • Immunohistochemistry
      • Flow Cytometry
      • In Situ Hybridization
      • Nucleic Acid Amplification Technologies
      • Analysis of Gene Expression Patterns (Gene Signatures)
      • Microarrays
      • Sequencing Technologies
      • Mass Spectrometry
      • Liquid Biopsies
      • Information Technology
    • Test Targets
      • Human Epidermal Growth Factor Receptor 2 (HER2) Overexpression
      • Epidermal Growth Factor Receptor
      • Kirsten Rat Sarcoma Mutations
      • BRAF Mutations
      • Uridine Diphosphate-Glucuronyl Transferase 1A1 Genetic Variants
      • 5-Fluorouracil Therapy
      • Phosphatidylinositol 3-Kinase Gene Mutations
      • Kinesin-Like Protein 6 Mutations
      • Anaplastic Lymphoma Kinase Mutations
    • Products on the Market
      • Table Select Personalized Medicine Testing Products for Cancer
    • Demand
      • Table Figure 1 | World Personalized Medicine Tests for Cancer Demand; 2016, 2021
      • Table World Personalized Medicine Tests for Cancer Demand; 2016, 2021
  • REGIONAL SEGMENTATION & FORECASTS
    • Regional Demand Overview
      • Table Figure 2 | World Personalized Medicine Tests for Cancer Demand by Region; 2016, 2021
      • Table World Personalized Medicine Tests for Cancer Demand by Region; 2016, 2021
  • INDUSTRY STRUCTURE
    • Industry Characteristics
      • Abbott Laboratories
      • BioMérieux
      • Quest Diagnostics
      • Roche Holding
  • ABOUT THIS REPORT
    • Scope & Method
    • Sources
    • Industry Codes
      • Table Industry Codes Related to Personalized Medicine Tests for Cancer
    • Resources

Abstract

World Personalized Medicine Tests for Cancer

This report forecasts total world demand in 2021 for personalized medicine tests for cancer by major world region in US dollars at the manufacturers' level. Major world regions include North America, the European Union, and the rest of the world.

To illustrate historical trends world demand (including regional segments) is provided for 2016. A World Overview and Forecasts section provides pertinent topical background, including technologies used, test targets, prroducts on the market, and global demand. A Regional Segmentation and Forecasts section provides an overview of demand by region.

Further analysis includes an Industry Structure section, which surveys the supply base and identifies the leading firms competing to serve global demand. An introductory Highlights section summarizes key findings from this 29-page report, and a Resources section lists contributing sources as well as resources available for further research.

Get full details about this report
(US): 800.298.5294
(Int): +1.240.747.3095
Fax: 240.747.3004